AlliMax® Nutraceuticals U.S. is headquartered in Chicago, Illinois, a forward-looking corporation with a rich history as a leader in the international stabilized Allicin industry, grounded in the pioneering research of Peter Josling, Biochemist, Author and Director of The Garlic Center based in Sussex, England.
AlliMax® Nutraceuticals U.S. mission is to identify, research and through clinical trials, find effective integration utilizing Allisure® AC-23 allicin to enhance nutritional technologies that promote wellness, through the superior integration of science.
Quality is paramount in every aspect of our business, from how we execute programs to how a product is produced. We provide the highest quality products produced according to Pharmaceutical, GMP and ISO 9000 standards.
AlliMed® Allisure AC-23 products offer you safe effective and scientifically proven nutraceuticals. Our extensive completed and ongoing clinical research ensures the latest delivery and formulation expertise. For copies of our research studies please contact our office.
AlliMed® Allisure AC-23 draws on solid biomedical science and best manufacturing practices to offer nutrition products that are revolutionizing the way we address chronic diseases and compromised immune systems.
AlliMax® Nutraceuticals U.S. is strategically positioned as a major player in the emerging shift in nutritional science involving stabilized Allicin, the result of a patented process of stabilizing Allicin, the active component of garlic resulting in a purified, living source of completely stable Allicin.